Healthcare Equipment and Supplies
Company Overview of Randox Laboratories Limited
Randox Laboratories Limited researches, designs, develops, manufactures, markets, and exports healthcare diagnostic products. The company offers biochip analyzers, immunoassays, and molecular diagnostics; clinical chemistry analyzers; diagnostic reagents; and multi-analyte liquid tumor marker controls. It also provides RIQAS, an external quality assessment scheme; and contract manufacturing services. In addition, the company offers Randox Molecular that provides a range of molecular arrays and assay formats to offer diagnostic, prognostic, and predictive solutions for infectious diseases, cardiovascular diseases, and cancer. It serves hospital laboratories, forensic laboratories, A&E units, ...
55 Diamond Road
Crumlin, BT29 4QY
Founded in 1982
Key Executives for Randox Laboratories Limited
Owner and Managing Director
Randox US QC Sales Director
Compensation as of Fiscal Year 2017.
Randox Laboratories Limited Key Developments
Transgene and Randox Sign Collaboration to Develop Innovative Multifunctional Oncolytic Virotherapies for Solid Tumors
Oct 2 17
Transgene and Randox entered into a collaboration to combine their technologies and develop multifunctional oncolytic immunotherapies. Innovative oncolytic viruses (OVs) resulting from this collaboration will use Transgene's proprietary viral platform Invir.IOTM in which one or more of Randox’s SdAbs (single-domain antibodies) will be vectorized. The immunotherapies resulting from this collaboration will combine the oncolytic effect of the viruses with the properties of the vectorized SdAbs that will be locally expressed in the tumor microenvironment (TME) with the aim of treating immunosuppressed solid tumors. Under the terms of the agreement, Transgene will develop novel anticancer oncolytic virus drugs using its proprietary Vaccinia virus (TK-, RR-) strain, and its expertise in molecular engineering and translational research. This novel viral strain offers increased oncolytic properties. In addition, its large genome capacity, which is very differentiating, enables multiple therapeutic payloads to be delivered in the tumor, where the virus replicates. Randox will provide expertise in antibody engineering and make available its collection of new and future immunotherapeutic SdAbs to be used as vectorized payloads. These SdAbs have the potential to modulate the patient’s immune response and produce a powerful synergistic effect with Transgene’s oncolytic viral platform. Transgene’s Invir.IOTM technology is an efficient way to target immunosuppressive pathways directly in the tumor microenvironment. By locally expressing one or several SdAbs in the TME, the viral-based approach promises to optimize the efficacy of the encoded therapeutic agents, while reducing their associated side effects, often reported after systemic administration. Novel OV products generated from the collaboration have the potential to be significantly more effective than a combination of single agents. Transgene previously reported a preclinical proof-of-concept data showing that an oncolytic Vaccinia virus encoding a sequence of anti-PD1 demonstrated better overall survival than the combination of separate single agents.
Randox Laboratories Limited Presents at Sachs Associates 10th Annual European Life Sciences CEO Forum & Exhibition, Mar-06-2017 05:00 PM
Mar 3 17
Randox Laboratories Limited Presents at Sachs Associates 10th Annual European Life Sciences CEO Forum & Exhibition, Mar-06-2017 05:00 PM. Venue: Hilton Zurich Airport Hotel, Hohenbuehlstrasse 10, Opfikon-Glattbrugg 8152 Zurich, Switzerland. Speakers: Claire Huguet, Head of Biomarker Services.
Randox Laboratories Wins Multiple Awardees Contract for Supplying Microbiology, Serology, Virology, Immunology Equipment, Consumables and Reagents
May 20 16
NORMANTON, United Kingdom, May 18 -- Randox Holdings Ltd. TA Randox Laboratories Ltd. UKN won a multiple awardees contract award from NHS Supply Chain acting as agent for NHS Business Services Authority for the supply of Randox Laboratories Ltd. won a multiple awardees contract award from NHS Supply Chain acting as agent for NHS Business Services Authority for the supply of microbiology, serology, virology and immunology equipment, consumables and reagents.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|